Field & Main Bank Edwards Lifesciences Corp Transaction History

Field & Main Bank

$279 Million
Q1 2025

A detailed history of Field & Main Bank transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Field & Main Bank holds 35 shares of EW stock, worth $2,654. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 100 65.0%

Holding current value

$2,654

Previous $7,000 71.43%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 23, 2025	SELL	$67.95 - $76.19 $4,416 - $4,952	-65 Reduced 65.0%	35 $2,000
Q3 2023 Oct 12, 2023	SELL	$69.28 - $93.38 $26,949 - $36,324	-389 Reduced 79.55%	100 $6,000
Q1 2023 Apr 19, 2023	SELL	$74.26 - $84.51 $5,569 - $6,338	-75 Reduced 13.3%	489 $40,000
Q3 2022 Oct 25, 2022	SELL	$82.37 - $107.29 $8,484 - $11,050	-103 Reduced 15.44%	564 $47,000
Q2 2022 Jul 18, 2022	BUY	$86.5 - $128.27 $27,420 - $40,661	317 Added 90.57%	667 $63,000
Q4 2021 Feb 01, 2022	SELL	$106.37 - $130.68 $13,296 - $16,335	-125 Reduced 26.32%	350 $45,000
Q3 2021 Oct 14, 2021	BUY	$102.91 - $122.75 $10,291 - $12,275	100 Added 26.67%	475 $54,000
Q4 2020 Feb 25, 2021	SELL	$71.69 - $91.23 $430 - $547	-6 Reduced 1.57%	375 $34,000
Q2 2020 Aug 12, 2020	BUY	$57.54 - $76.95 $11,738 - $15,697	204 Added 115.25%	381 $26,000
Q1 2019 Apr 24, 2019	SELL	$47.89 - $64.05 $1,580 - $2,113	-33 Reduced 15.71%	177 $34,000
Q3 2018 Oct 23, 2018	SELL	$45.7 - $58.03 $1,279 - $1,624	-28 Reduced 11.76%	210 $37,000
Q2 2018 Aug 13, 2018	BUY	$42.45 - $51.3 $2,334 - $2,821	55 Added 30.05%	238 $34,000
Q4 2017 Jan 24, 2018	BUY	$33.79 - $39.39 $6,183 - $7,208	183	183 $21,000

Others Institutions Holding EW

# of Institutions

1,376

Shares Held

486M

Call Options Held

2.77M

Put Options Held

2.05M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $46.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Field & Main Bank, based on Form 13F filings with the SEC.

News

Stay updated on Field & Main Bank with notifications on news.

Account